Disease/Infection News

RSS

New genetic study suspects Armadillos as source of leprosy in the U.S.

A new genetic study on leprosy bacteria reports that armadillos may be a source of infection in the Southern United States.

29 Apr 2011

New innovative pilot project to combat surgical infections

Roughly one out of every 24 patients undergoing surgery acquires a surgical site infection. With 40 million operations performed in the U.S. each year, between 800,000 and 2 million individuals contract these infections annually.

29 Apr 2011

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers at the University of Illinois at Chicago's Center for Pharmaceutical Biotechnology have been awarded a federal contract for up to $13.8 million to develop antibiotics to treat anthrax, tularemia and plague.

28 Apr 2011

CBI, Children's Rare Disease Network and Global Genes Project partner for Rare Disease Leadership Summit

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.

28 Apr 2011

PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced the launch of its proprietary new brand, PURE Hard Surface disinfectant and food contact surface sanitizer at the 2011 California State PTA Annual Convention being held April 28 - May 1 in Long Beach, California.

28 Apr 2011

Hepatitis B virus rebound common in patients receiving nucleoside analogs for chronic hepatitis B

A rebound of the Hepatitis B virus is common in patients receiving nucleoside analogs for chronic hepatitis B, according to a study from U-M hepatologists. But nearly 40% of the rebounds or virological breakthroughs (VBTs) were not related to antiviral drug resistance.

28 Apr 2011

CMA and AFN call federal leaders to modernize Canada Health Act

The Canadian Medical Association and the Assembly of First Nations today called on federal leaders to commit to defending and modernizing the Canada Health Act and enhancing the health of First Nations peoples across Canada.

28 Apr 2011

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.

28 Apr 2011

Researchers begin approved drugs screening for clinical use against rare diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.

28 Apr 2011

TB screening misses immigrants: Study

According to a latest study published in The Lancet, one in five new immigrants to the UK from the Indian subcontinent, and almost a third from sub-Saharan Africa, carried latent tuberculosis (TB).

28 Apr 2011

Stop malaria by taking precautions before travelling to endemic zones

More than half of UK malaria cases are seen in people visiting friends and relatives in West Africa and India. The World Health Organization (WHO) estimates there were 243 million cases of malaria in 2008 and almost a million deaths worldwide.

28 Apr 2011

IL28B gene plays a key role in spontaneous HCV clearance in infants

New research shows that high maternal viral load and co-infection with human immunodeficiency virus are the only risk factors associated with vertical transmission of the hepatitis C virus.

28 Apr 2011

Seattle BioMed study to identify biomarkers for malaria vaccine design

In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.

28 Apr 2011

NIH awards UH with $361,000 grant for chikungunya vaccine study

It is spread to humans by mosquito bites, causing arthritic symptoms so severe that some victims can't even walk. While rarely fatal, the effects of the chikungunya virus can last up to a year.

28 Apr 2011

Low-cost colorimetric sensing array identifies bacterial infections

Bacterial infections really stink. And that could be the key to a fast diagnosis.

28 Apr 2011

FDA Advisory Committee recommends approval of Merck's VICTRELIS for chronic HCV genotype 1 infection

Merck announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously that the available data support approval of Merck's investigational medicine VICTRELIS™ (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy.

28 Apr 2011

Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program

Rwandan First Lady Jeannette Kagame on Tuesday, in collaboration with two companies, launched a national cervical cancer vaccination and screening program, the first of its kind in Africa, the New Times reports.

27 Apr 2011

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Medecins Sans Frontieres recently sent a letter to Johnson & Johnson criticizing the pharmaceutical company for "refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries," the Star-Ledger reports.

27 Apr 2011

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced it has accepted delivery of the world's first integrated optical biosensor for disease diagnosis.

27 Apr 2011

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.

27 Apr 2011

Disease/Infection News

New genetic study suspects Armadillos as source of leprosy in the U.S.

New innovative pilot project to combat surgical infections

UIC receives federal contract to develop antibiotics against three bacterial infections

CBI, Children's Rare Disease Network and Global Genes Project partner for Rare Disease Leadership Summit

PURE Bioscience introduces new Hard Surface disinfectant

Hepatitis B virus rebound common in patients receiving nucleoside analogs for chronic hepatitis B

CMA and AFN call federal leaders to modernize Canada Health Act

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Researchers begin approved drugs screening for clinical use against rare diseases

TB screening misses immigrants: Study

Stop malaria by taking precautions before travelling to endemic zones

IL28B gene plays a key role in spontaneous HCV clearance in infants

Seattle BioMed study to identify biomarkers for malaria vaccine design

NIH awards UH with $361,000 grant for chikungunya vaccine study

Low-cost colorimetric sensing array identifies bacterial infections

FDA Advisory Committee recommends approval of Merck's VICTRELIS for chronic HCV genotype 1 infection

Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Biomagnetics accepts Los Alamos National Labs' optical biosensor for disease diagnosis

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News